SAB Biotherapeutics Cash Flow Statement 2020-2025 | SABS

Fifteen years of historical annual cash flow statements for SAB Biotherapeutics (SABS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-34.11$-42.19$-18.74$-17.14$20.12
$4.56$3.75$3.29$1.65$0.55
$-2.44$11.00$-7.77$5.79$1.29
$2.11$14.75$-4.48$7.45$1.84
$0$5.56$2.45$12.56$-17.75
$0$0$0$0$0
$0.92$-2.70$-0.78$-2.94$5.21
$-3.22$-0.53$-1.91$2.06$0.58
$-2.30$2.33$-0.24$11.68$-11.95
$-34.29$-25.12$-23.46$1.99$10.00
$-0.34$-0.15$-2.09$-10.94$-12.72
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-11.63$0$0$0$0
$-11.63$0$0$0$0
$0$0$0$0$0
$-11.96$-0.15$-2.09$-10.94$-12.72
$-0.13$-0.13$-0.16$-1.30$-0.18
$-0.78$-0.26$-1.02$2.84$-1.40
$-0.91$-0.39$-1.19$1.54$-1.58
$0.02$67.16$7.76$0.01$9.90
$0.02$67.16$7.76$0.01$9.90
$0$0$0$0$0
$-0.29$0$-5.52$34.34$0.66
$-1.17$66.77$1.05$35.89$8.98
$-47.67$41.52$-24.50$26.93$6.26
$2.94$2.42$2.67$2.31$1.30
$0$0$0$0$0